No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 8.8x · 10Y median 9.6x · 44th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 24
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T17:53:10.246Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Seer, Inc. (SEER) stock was $2.22 as of Oct 6, 2026, 1:50 PM EDT, down 4.94% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +2.2% · 3-year avg +3.5%/yr · 5-year avg -41.0%/yr
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome.
Biotechnology · Redwood City, CA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2023-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 5, 2026
30 days away
EPS Estimate
-0.26
Revenue Est.
$4.15M
Last Quarter Results
EPS
$-0.31
vs Estimate
$-0.27
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1SEER | $121.78M | $2.21 | -4.94% | +2.18% | -40.97% | N/A | N/A |
| 2HURA | $121.95M | $1.92 | +2.41% | -27.96% | -45.49% | -52.09% | vs SEER |
| 3CBUS | $121.37M | $1.59 | -5.36% | +16.58% | -59.70% | N/A | vs SEER |
| 4ENGN | $120.92M | $1.80 | -3.48% | -75.71% | N/A | N/A | vs SEER |
| 5BGM | $123.07M | $9.70 | +3.74% | -96.69% | N/A | N/A | vs SEER |
| 6SPRB | $120.11M | $43.64 | -3.92% | -65.29% | -36.23% | N/A | vs SEER |
N/A
$3.10M
vs Estimate
$3.55M
Consensus Rating
Based on 1 analyst
Average Price Target
$4.00
+80.6% upside
Low
$4.00
Current
$2.21
High
$4.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.27 | $-0.26 | $-0.25 | 2 |
| Quarter ending Dec 2026 | $-0.23 | $-0.22 | $-0.21 | 2 |
| Quarter ending Mar 2027 | $-0.27 | $-0.27 | $-0.26 | 1 |
| Quarter ending Jun 2027 | $-0.27 | $-0.27 | $-0.26 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-1.18 | $-1.10 | $-1.02 | 1 |
| FY 2027 | $-1.13 | $-1.05 | $-0.98 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $3.90M | $4.15M | $4.40M | 2 |
| Quarter ending Dec 2026 | $6.00M | $6.10M | $6.20M | 2 |
| Quarter ending Mar 2027 | $4.03M | $4.10M | $4.17M | 1 |
| Quarter ending Jun 2027 | $4.48M | $4.55M | $4.62M | 1 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $15.21M | $16.10M | $16.99M | 1 |
| FY 2027 | $17.50M | $19.40M | $21.30M | 2 |
